- Stocks
- Healthcare
CBLL
CeriBell, Inc.
CBLL
NASDAQ·Healthcare·Medical - Devices·Mkt cap $900.4M
$23.73
▲ +1.54%
P/E
-32.51
Mkt Cap
$900.4M
52-Wk Range
$10.85–$25.33
52-Week Range
$10.85 - $25.33
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 107.8% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
3 reasons
- Proprietary AI algorithms for real-time neurological detection
- Portable, user-friendly point-of-care platform vs. traditional EEG systems
- FDA-cleared technology with clinical validation in acute care settings
Bear Case
1 risk
- Average volatility.
Growth
Moderate growth ahead
Rising prevalence of seizure disorders and neurological emergencies
Value
Trading at 0.0x Medical Devices peers — a discount despite the growth profile.
Momentum
Hot
+28.6% over 3m
Quality
Excellent
High-growth business (32% revenue growth, 89% gross margin). Pre-profit but investing in growth.
Dividend
None
No dividend
Smart-money signal
Who's buying CBLL right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 3, 2026
AUG 10, 2026
Reported EPS of -$0.51 vs -$0.47 consensus (-8.2% surprise). Revenue of $28.1M vs $27.3M expected (+3.0%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-8.2%
Revenue trend · last 8Q
—
+41%
+38%
+43%
+31%
+34%
+29%
+33%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$17.2M
$18.5M
$20.5M
$21.2M
$22.6M
$24.8M
$26.5M
$28.1M
Margins · last 8Q
Gross
92.3%
Operating
-71.1%
Profit
70.3%
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Canaccord · $25.00 · May 12, 2026
vs Industry
How CBLL stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related